Guardant Health (GH) Operating Leases (2019 - 2026)

Guardant Health (GH) has 8 years of Operating Leases data on file, last reported at $173.1 million in Q1 2026.

• Quarterly Operating Leases fell 8.94% year-over-year to $173.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $173.1 million (down 8.94% YoY) and the FY2025 annual result came in at $178.5 million, up 8.63% from the prior year.
• Operating Leases declined to $173.1 million in Q1 2026 per GH's latest filing, from $178.5 million in the prior quarter.
• The five-year high for Operating Leases was $240.8 million in Q2 2022, with the low at $164.3 million in Q4 2024.
• Average Operating Leases over 5 years is $200.5 million, with a median of $199.9 million recorded in 2024.
• Year-over-year, Operating Leases rose 13.7% in 2022 and decreased 22.33% in 2024.
• Guardant Health's Operating Leases stood at $210.0 million in 2022, then fell by 11.51% to $185.8 million in 2023, then dropped by 11.6% to $164.3 million in 2024, then increased by 8.63% to $178.5 million in 2025, then decreased by 3.03% to $173.1 million in 2026.
• Business Quant data shows GH's Operating Leases at $173.1 million in Q1 2026, $178.5 million in Q4 2025, and $185.4 million in Q3 2025.